Logo image of FMS

FRESENIUS MEDICAL CARE-ADR (FMS) Stock Overview

USA - NYSE:FMS - US3580291066 - ADR

27.24 USD
+0.32 (+1.19%)
Last: 10/24/2025, 8:25:52 PM
27.24 USD
0 (0%)
After Hours: 10/24/2025, 8:25:52 PM

FMS Key Statistics, Chart & Performance

Key Statistics
Market Cap15.99B
Revenue(TTM)19.52B
Net Income(TTM)656.42M
Shares586.83M
Float419.26M
52 Week High30.46
52 Week Low18.94
Yearly Dividend0.69
Dividend Yield3.1%
EPS(TTM)2.02
PE13.49
Fwd PE11.13
Earnings (Next)11-04 2025-11-04
IPO1996-10-02
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


FMS short term performance overview.The bars show the price performance of FMS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8 10

FMS long term performance overview.The bars show the price performance of FMS in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of FMS is 27.24 USD. In the past month the price increased by 6.49%. In the past year, price increased by 30.15%.

FRESENIUS MEDICAL CARE-ADR / FMS Daily stock chart

FMS Latest News, Press Relases and Analysis

FMS Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 12.92 103.91B
CI THE CIGNA GROUP 10.74 80.55B
LH LABCORP HOLDINGS INC 18.46 23.23B
DGX QUEST DIAGNOSTICS INC 18.67 20.37B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 153.35 20.10B
HIMS HIMS & HERS HEALTH INC 60.98 11.03B
DVA DAVITA INC 13.33 9.24B
GH GUARDANT HEALTH INC N/A 9.00B
RDNT RADNET INC 231.69 6.42B
CHE CHEMED CORP 19.52 6.36B
BTSG BRIGHTSPRING HEALTH SERVICES 45.31 5.94B
OPCH OPTION CARE HEALTH INC 20.67 4.53B

About FMS

Company Profile

FMS logo image Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 112,445 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.

Company Info

FRESENIUS MEDICAL CARE-ADR

Else-Kroener-Strasse 1

Bad Homburg vor der Hohe HESSEN 61352 DE

CEO: Rice Powell

Employees: 112445

FMS Company Website

FMS Investor Relations

Phone: 4961726090

FRESENIUS MEDICAL CARE-ADR / FMS FAQ

What does FMS do?

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 112,445 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.


What is the stock price of FRESENIUS MEDICAL CARE-ADR today?

The current stock price of FMS is 27.24 USD. The price increased by 1.19% in the last trading session.


Does FRESENIUS MEDICAL CARE-ADR pay dividends?

FRESENIUS MEDICAL CARE-ADR (FMS) has a dividend yield of 3.1%. The yearly dividend amount is currently 0.69.


What is the ChartMill technical and fundamental rating of FMS stock?

FMS has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is FRESENIUS MEDICAL CARE-ADR (FMS) stock traded?

FMS stock is listed on the New York Stock Exchange, Inc. exchange.


How is the valuation of FRESENIUS MEDICAL CARE-ADR (FMS) based on its PE ratio?

The PE ratio for FRESENIUS MEDICAL CARE-ADR (FMS) is 13.49. This is based on the reported non-GAAP earnings per share of 2.02 and the current share price of 27.24 USD.


Can you provide the upcoming earnings date for FRESENIUS MEDICAL CARE-ADR?

FRESENIUS MEDICAL CARE-ADR (FMS) will report earnings on 2025-11-04.


FMS Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to FMS. When comparing the yearly performance of all stocks, FMS is one of the better performing stocks in the market, outperforming 77.76% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FMS Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to FMS. FMS has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FMS Financial Highlights

Over the last trailing twelve months FMS reported a non-GAAP Earnings per Share(EPS) of 2.02. The EPS increased by 17.17% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.36%
ROA 2.1%
ROE 4.95%
Debt/Equity 0.71
Chartmill High Growth Momentum
EPS Q2Q%30%
Sales Q2Q%0.55%
EPS 1Y (TTM)17.17%
Revenue 1Y (TTM)0.53%

FMS Forecast & Estimates

25 analysts have analysed FMS and the average price target is 29.49 USD. This implies a price increase of 8.26% is expected in the next year compared to the current price of 27.24.

For the next year, analysts expect an EPS growth of 17.76% and a revenue growth 1.28% for FMS


Analysts
Analysts67.2
Price Target29.49 (8.26%)
EPS Next Y17.76%
Revenue Next Year1.28%

FMS Ownership

Ownership
Inst Owners43.16%
Ins OwnersN/A
Short Float %0.21%
Short Ratio2.83